You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drugs Containing Excipient (Inactive Ingredient) SORBITOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing SORBITOL excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing SORBITOL excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Sorbitol

Introduction to Sorbitol in Pharmaceuticals

Sorbitol, also known as glucitol, is a polyol that has become a versatile and essential excipient in the pharmaceutical industry. Its unique properties make it an ideal component in various drug formulations, contributing significantly to the stability, efficacy, and safety of pharmaceutical products.

Market Size and Growth

The global sorbitol market is experiencing robust growth, driven largely by its increasing use in pharmaceutical and personal care products. As of 2023, the sorbitol market size was valued at $1.71 billion and is projected to grow to $1.83 billion in 2024, with a compound annual growth rate (CAGR) of 6.7%[1].

By 2028, the market is expected to reach $2.39 billion, growing at a CAGR of 6.9%. This growth is attributed to several factors, including the expanding use of sorbitol in pharmaceutical formulations, increased emphasis on health and wellness, and growing consumer preference for natural and plant-based sweeteners[1].

Functions of Sorbitol as a Pharmaceutical Excipient

Sorbitol serves multiple roles in pharmaceutical formulations:

  • Sweetener, Humectant, and Stabilizer: Sorbitol is used to enhance the taste, maintain moisture levels, and stabilize the formulation in oral liquid preparations, tablets, and capsules[2].
  • Drug Delivery Vehicle: It acts as a vehicle for drug delivery in chewable tablets and lozenges, ensuring effective and controlled release of the active pharmaceutical ingredient (API)[2].
  • Oral Care Products: Sorbitol’s non-cariogenic and osmotic properties make it suitable for use in oral care products, contributing to better oral health outcomes[2].

Drivers of Market Growth

Several factors are driving the growth of the sorbitol market in the pharmaceutical sector:

  • Growing Emphasis on Sustainability: The increasing focus on sustainable and eco-friendly products is boosting the demand for sorbitol, which is derived from natural sources[1].
  • Health and Wellness Trends: The rising interest in health and wellness is leading to increased use of sorbitol in pharmaceutical and personal care products, as it is perceived as a healthier alternative to traditional sweeteners[1].
  • Regulatory Support: Continued regulatory support for the use of sorbitol in pharmaceutical formulations is another significant driver of market growth[1].
  • Technological Advancements: Innovations in manufacturing processes and the development of new product formulations are further enhancing the demand for sorbitol[1].

Regional Analysis

The global sorbitol market is geographically diverse, but certain regions are expected to dominate the market:

  • Asia Pacific: This region is anticipated to lead the sorbitol market due to substantial industrial growth, increasing consumer demand, and the presence of large manufacturing capabilities in countries like China and India. Rapid urbanization and an expanding middle class in these countries are also driving the demand for sorbitol-containing products[4].

Impact on Pharmaceutical Formulations

Sorbitol can influence the pharmacokinetics of certain drugs:

  • Bioavailability and Absorption: Studies have shown that sorbitol can alter the oral absorption and bioavailability of some drugs. For instance, it may decrease the bioavailability of drugs like risperidone and lamivudine when used in solution formulations. However, it does not affect the pharmacokinetics of all drugs equally, with some, like cimetidine and acyclovir, showing no changes[5].

Biopharmaceutical Excipients Market Context

The broader biopharmaceutical excipients market, within which sorbitol plays a part, is also experiencing significant growth. This market was valued at $2.57 billion in 2023 and is expected to reach $4.04 billion by 2032, growing at a CAGR of 5.18% from 2024 to 2032. The growth is driven by the expansion of biologics and biosimilar therapies, as well as advancements in high-concentration drug formulations[3].

Innovations and Emerging Trends

Several trends are shaping the future of the sorbitol market:

  • Expansion in Personal Care and Cosmetics: The use of sorbitol in personal care and cosmetics is expanding, driven by its moisturizing and stabilizing properties[1].
  • Growth in Pharmaceuticals: The increasing use of sorbitol as an excipient in pharmaceutical formulations, particularly in oral and topical applications, is a key trend[1][4].
  • Technological Advancements: Innovations in manufacturing and formulation technologies are enhancing the efficiency and effectiveness of sorbitol in various applications[1].

Challenges and Considerations

While sorbitol offers numerous benefits, there are several factors that pharmaceutical formulators need to consider:

  • Manufacturability: The ease of processing, blending, and compressibility of sorbitol must be evaluated to ensure it contributes to the overall manufacturability of the product[2].
  • Stability: The stability of sorbitol under storage conditions is crucial, and any potential degradation products must be identified and monitored[2].

Key Takeaways

  • Market Growth: The sorbitol market is expected to grow significantly, reaching $2.39 billion by 2028.
  • Versatile Applications: Sorbitol is used as a sweetener, humectant, stabilizer, and drug delivery vehicle in various pharmaceutical formulations.
  • Regional Dominance: The Asia Pacific region is expected to dominate the sorbitol market due to industrial growth and consumer demand.
  • Impact on Pharmacokinetics: Sorbitol can affect the bioavailability and absorption of certain drugs.
  • Innovations and Trends: The market is driven by health and wellness trends, technological advancements, and growing emphasis on sustainability.

FAQs

What are the primary functions of sorbitol in pharmaceutical formulations?

Sorbitol acts as a sweetener, humectant, stabilizer, and drug delivery vehicle in pharmaceutical formulations, including oral liquid preparations, tablets, and capsules.

How is the sorbitol market expected to grow in the coming years?

The sorbitol market is expected to grow from $1.71 billion in 2023 to $2.39 billion by 2028, with a CAGR of 6.9%.

Which region is expected to dominate the sorbitol market?

The Asia Pacific region is anticipated to dominate the sorbitol market due to substantial industrial growth, increasing consumer demand, and large manufacturing capabilities.

Can sorbitol affect the bioavailability of drugs?

Yes, sorbitol can alter the oral absorption and bioavailability of certain drugs, although the impact varies depending on the drug and formulation type.

What are some of the key drivers of the sorbitol market growth?

Key drivers include the growing emphasis on sustainability, health and wellness trends, regulatory support, and technological advancements.

Sources

  1. The Business Research Company, "Sorbitol Market Report 2024 - Sorbitol Market Size, Growth And Trends"
  2. Pharma Excipients, "Sorbitol as Pharmaceutical Excipient"
  3. SNS Insider, "Biopharmaceutical Excipients Market Size, Trends & Growth, 2032"
  4. Verified Market Research, "In-Depth Industry Outlook: Sorbitol Market Size & Forecast"
  5. PubMed, "Use of sorbitol as pharmaceutical excipient in the present day ..."

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.